Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab-MedSci.cn - 梅斯（MedSci）

Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab

Zhang, LY

Zhang, LY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China.

ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2021; 8 (4): 349

科室
- - 订阅+
  - 更多科室
工具
服务